EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

De‐Escalating Surgery for 1–2 cm Appendiceal Neuroendocrine Tumors: A North American Multi‐Center Analysis

Richard Max Miller iD, Po Hong Tan, Andrew Saleeb, Emily R Thompson, Zhi Ven Fong, Chee-Chee Stucky, Sanjay P Bagaria, Emmanuel M Gabriel, Travis E Grotz iD, Nabil Wasif

Journal of Surgical Oncology · 2026-07 · 134 (1) · 91-100

DOI: 10.1002/jso.70274 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Surgical Oncology, online erschienen am 29.04.2026. Verfasst von Richard Max Miller und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Appendiceal Neoplasms, Neuroendocrine Tumors, Appendectomy, Colectomy. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mayo Clinic Arizona Department of Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives NCCN guidelines recommend right hemicolectomy (RHC) for appendiceal neuroendocrine tumors (aNETs) > 2 cm and observation for < 1 cm. However, optimal surgical management of 1–2 cm tumors remains controversial. This study compared long‐term survival and recurrence between patients undergoing RHC versus appendectomy (APY) for 1–2 cm aNETs.

Methods

Patients with pathologically confirmed 1–2 cm aNETs treated at three Mayo Clinic sites (1972–2024) were included. Primary outcomes were recurrence and all‐cause mortality after resection. Associations with lymph node (LN) metastasis were assessed in patients with lymphadenectomy.

Results

Sixty‐five patients were identified: 29 (45%) underwent APY, 35 (54%) RHC, and one ileocecectomy. Median age at diagnosis was 39 years; 71% were female and 94% white. LN positivity was 15.2% for tumors with nodes examined. Tumor size > 1.5 cm, stage T3/T4, and lymphovascular invasion were not associated with nodal metastasis. No survival differences were observed between APY and RHC. LN positivity did not impact survival. No recurrences occurred during a median follow‐up of 6.25 years (IQR 2.44–12.63).

Conclusions

Among patients with 1–2 cm aNETs, RHC conferred no survival benefit over APY. Absence of recurrence and the limited prognostic value of nodal disease suggest APY alone may suffice for this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Appendiceal NeoplasmsNeuroendocrine TumorsAppendectomyColectomyHumansFemaleAdultMaleMiddle AgedNeoplasm Recurrence, LocalSurvival RateLymphatic MetastasisLymph Node ExcisionRetrospective StudiesFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

ENETS guidelinesNCCN guidelinesappendectomyappendiceal neuroendocrine tumorsappendix cancerright hemicolectomy

Autor:innen und Institutionen

  • Department of Surgery, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Surgery, Mayo Clinic, Jacksonville, Florida, USA.
  • Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Richard Max Miller, Travis E Grotz

Förderung

  • Mayo Clinic Arizona Department of Surgery

Zitieren

APA

Miller, R. M., Tan, P. H., Saleeb, A., Thompson, E. R., Fong, Z. V., Stucky, C. C., Bagaria, S. P., Gabriel, E. M., Grotz, T. E., & Wasif, N. (2026). De‐Escalating Surgery for 1–2 cm Appendiceal Neuroendocrine Tumors: A North American Multi‐Center Analysis. Journal of Surgical Oncology, 134(1), 91-100. https://doi.org/10.1002/jso.70274

Vancouver

Miller RM, Tan PH, Saleeb A, Thompson ER, Fong ZV, Stucky CC, et al. De‐Escalating Surgery for 1–2 cm Appendiceal Neuroendocrine Tumors: A North American Multi‐Center Analysis. Journal of Surgical Oncology. 2026;134(1):91-100. doi:10.1002/jso.70274

BibTeX
@article{Miller2026,
  author = {Miller, Richard Max and Tan, Po Hong and Saleeb, Andrew and Thompson, Emily R and Fong, Zhi Ven and Stucky, Chee-Chee and Bagaria, Sanjay P and Gabriel, Emmanuel M and Grotz, Travis E and Wasif, Nabil},
  title = {De‐Escalating Surgery for 1–2 cm Appendiceal Neuroendocrine Tumors: A North American Multi‐Center Analysis},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {134},
  number = {1},
  pages = {91--100},
  doi = {10.1002/jso.70274}
}
Kostenlos starten →